REGISTERED
on 12 Oct 2021
Last Applicant/ Owned by
50 Binney Street
Cambridge
MA
02142
Serial Number
88318614 filed on 27th Feb 2019
Registration Number
6521238 registered on 12th Oct 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
NEXVIAZYME
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, vir Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
First Use Date in General
18th Aug 2021
First Use Date in Commerce
18th Aug 2021
Mark Details
Serial Number
No 88318614
Mark Type
No Service/Collective Mark
Attorney Docket Number
No GENZ 1903533
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Oct 2021 | REGISTERED-PRINCIPAL REGISTER |
| 09th Sep 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 08th Sep 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 08th Sep 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 07th Sep 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 31st Aug 2021 | USE AMENDMENT FILED |
| 31st Aug 2021 | TEAS STATEMENT OF USE RECEIVED |
| 28th May 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th May 2021 | EXTENSION 4 GRANTED |
| 26th May 2021 | TEAS EXTENSION RECEIVED |